Cargando…
Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
Therapeutic drug monitoring for drug-resistant tuberculosis (TB) is likely to improve treatment outcomes. While assessments of plasma drug levels can explain pharmacokinetic variability among trial participants, these measures require phlebotomy and a cold chain, and are generally not repeated frequ...
Autores principales: | Metcalfe, John, Bacchetti, Peter, Gerona, Roy, Esmail, Ali, Dheda, Keertan, Gandhi, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484095/ https://www.ncbi.nlm.nih.gov/pubmed/31041318 http://dx.doi.org/10.1183/23120541.00046-2019 |
Ejemplares similares
-
Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting
por: Metcalfe, John, et al.
Publicado: (2021) -
MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017) -
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016) -
Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis
por: Gerona, Roy, et al.
Publicado: (2016) -
Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)